30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

China Biologic Products Holdings Inc (CBPO)

Track

Stock chart
Ticker: CBPO Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Liu Zhijing CBPO
Corporate Vice President
1 sale — total 131,787 USD
Sale 9 May 2017
Value US$2,506,943.35 | Price 230.77 | Shares 56,490
Sale 8 May 2017
Value US$1,816,249.53 | Price 63.94 | Shares 23,534
Sale 2 Mar 2017
Value US$1,612,800.00 | Price 100.80 | Shares 16,000
Sale 1 Mar 2017
Value US$402,800.00 | Price 100.70 | Shares 4,000
Sale 1 Mar 2017
Value US$5,435,707.93 | Price 100.57 | Shares 54,049
Sale 28 Feb 2017
Value US$6,303,596.76 | Price 100.69 | Shares 62,604
Sale 15 Aug 2016
Value US$2,527,922.88 | Price 124.32 | Shares 20,334
Sale 15 Aug 2016
Value US$360,528.00 | Price 124.32 | Shares 2,900
Sale 15 Aug 2016
Value US$244,661.76 | Price 124.32 | Shares 1,968
Sale 15 Aug 2016
Value US$2,622,157.44 | Price 124.32 | Shares 21,092
Sale 15 Aug 2016
Value US$1,044,288.00 | Price 124.32 | Shares 8,400
Sale 8 Jun 2016
Value US$308,025,000.00 | Price 111.00 | Shares 2,775,000
Sale 8 Jun 2016
Value US$308,025,000.00 | Price 111.00 | Shares 2,775,000
Sale 8 Jun 2016
Value US$308,025,000.00 | Price 111.00 | Shares 2,775,000
Sale 20 May 2016
Value US$695,028.60 | Price 113.40 | Shares 6,129
Sale 20 May 2016
Value US$980,343.00 | Price 113.40 | Shares 8,645
Sale 20 May 2016
Value US$1,327,347.00 | Price 113.40 | Shares 11,705
Sale 19 May 2016
Value US$885,483.57 | Price 113.83 | Shares 7,779
Sale 19 May 2016
Value US$1,249,056.59 | Price 113.83 | Shares 10,973
Sale 19 May 2016
Value US$1,691,286.14 | Price 113.83 | Shares 14,858
Sale 11 Mar 2016
Value US$30,456.00 | Price 108.00 | Shares 282
Sale 7 Mar 2016
Value US$455,499,000.00 | Price 107.00 | Shares 4,257,000
Sale 7 Mar 2016
Value US$455,499,000.00 | Price 107.00 | Shares 4,257,000
Sale 7 Mar 2016
Value US$455,499,000.00 | Price 107.00 | Shares 4,257,000
Sale 7 Dec 2015
Value US$537,166.00 | Price 119.00 | Shares 4,514
Sale 4 Dec 2015
Value US$1,180,000.00 | Price 118.00 | Shares 10,000
Sale 4 Dec 2015
Value US$57,834.00 | Price 119.00 | Shares 486
Planned sale 4 Nov 2015
Value US$859,317.40 | Price 115.19 | Shares 7,460
Planned sale 2 Nov 2015
Value US$461,115.18 | Price 115.02 | Shares 4,009
Planned sale 29 Oct 2015
Value US$1,041,136.64 | Price 110.08 | Shares 9,458
Planned sale 26 Oct 2015
Value US$662,423.51 | Price 105.33 | Shares 6,289
Sale 15 Sep 2015
Value US$851,040.00 | Price 94.56 | Shares 9,000
Sale 15 Sep 2015
Value US$1,243,133.10 | Price 94.65 | Shares 13,134
Sale 14 Sep 2015
Value US$263,603.34 | Price 97.02 | Shares 2,717
Sale 14 Sep 2015
Value US$673,781.94 | Price 99.29 | Shares 6,786
Sale 14 Sep 2015
Value US$518,183.82 | Price 97.02 | Shares 5,341
Sale 15 Jun 2015
Value US$265,227,375.00 | Price 100.28 | Shares 2,645,000
Sale 15 Jun 2015
Value US$265,227,375.00 | Price 100.28 | Shares 2,645,000
Sale 15 Jun 2015
Value US$265,227,375.00 | Price 100.28 | Shares 2,645,000
Sale 21 Nov 2014
Value US$551,600.00 | Price 68.95 | Shares 8,000
Sale 10 Nov 2014
Value US$156,875.00 | Price 62.75 | Shares 2,500
Sale 10 Nov 2014
Value US$1,882,500.00 | Price 62.75 | Shares 30,000
Sale 10 Nov 2014
Value US$2,510,000.00 | Price 62.75 | Shares 40,000
Sale 10 Nov 2014
Value US$470,625.00 | Price 62.75 | Shares 7,500
Sale 10 Nov 2014
Value US$444,270.00 | Price 62.75 | Shares 7,080
Sale 10 Nov 2014
Value US$31,375.00 | Price 62.75 | Shares 500
Buy 14 May 2013
Value US$62,258,400.00 | Price 20.00 | Shares 3,112,920
Sale 28 Nov 2012
Value US$3,000,000.00 | Price 15.00 | Shares 200,000
Buy 13 Sep 2012
Value US$44,641.00 | Price 8.93 | Shares 5,000
Buy 1 Jun 2012
Value US$20,104,537.50 | Price 12.50 | Shares 1,608,363
Buy 14 May 2012
Value US$25,745.00 | Price 9.50 | Shares 2,710
Buy 11 May 2012
Value US$40,755.00 | Price 9.50 | Shares 4,290
Buy 16 Dec 2011
Value US$2,895,930.93 | Price 11.44 | Shares 253,236
Buy 15 Dec 2011
Value US$2,447,939.91 | Price 11.33 | Shares 216,146
Buy 14 Dec 2011
Value US$432,488.31 | Price 11.59 | Shares 37,315
Sale 14 Dec 2011
Value US$58,000.00 | Price 11.60 | Shares 5,000
Buy 13 Dec 2011
Value US$371,569.94 | Price 11.65 | Shares 31,904
Sale 13 Dec 2011
Value US$233,850.00 | Price 11.69 | Shares 20,000
Sale 12 Dec 2011
Value US$283,500.00 | Price 11.34 | Shares 25,000
Buy 12 Dec 2011
Value US$535,241.43 | Price 11.28 | Shares 47,461
Buy 9 Dec 2011
Value US$572,012.00 | Price 11.53 | Shares 49,600
Buy 8 Dec 2011
Value US$360,129.70 | Price 11.01 | Shares 32,723
Buy 7 Dec 2011
Value US$263,360.94 | Price 10.51 | Shares 25,066
Buy 5 Dec 2011
Value US$951,860.16 | Price 10.10 | Shares 94,210
Buy 5 Dec 2011
Value US$63,781.26 | Price 9.62 | Shares 6,630
Buy 2 Dec 2011
Value US$16,492.03 | Price 9.43 | Shares 1,748
Buy 1 Dec 2011
Value US$52,638.93 | Price 8.58 | Shares 6,133
Buy 30 Nov 2011
Value US$118,807.79 | Price 7.78 | Shares 15,267
Buy 29 Nov 2011
Value US$208,414.04 | Price 7.33 | Shares 28,421
Buy 27 May 2011
Value US$1,770,875.00 | Price 16.14 | Shares 109,721
Buy 26 May 2011
Value US$1,584,111.31 | Price 16.26 | Shares 97,440
Buy 25 May 2011
Value US$544,776.36 | Price 15.41 | Shares 35,362
Buy 24 May 2011
Value US$3,896,408.40 | Price 15.15 | Shares 257,114
Buy 23 May 2011
Value US$220,290.18 | Price 14.82 | Shares 14,869
Buy 20 May 2011
Value US$298,629.27 | Price 14.91 | Shares 20,030
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-05-10 2017-05-09 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
56,490 -7.3%
230.77
US$2,506,943 		56,490 -7.3% 230.77 US$2,506,943
2017-05-10 2017-05-08 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
23,534 -33.7%
63.94
US$1,816,250 		23,534 -33.7% 63.94 US$1,816,250
2017-03-03 2017-03-02 S Sale Shao Sean
5,231 +17.1%
58.15
US$4,575,290 		5,231 +17.1% 58.15 US$4,575,290
2017-03-03 2017-03-01 S Sale Shao Sean
4,000 -10.0%
100.70
US$402,800 		4,000 -10.0% 100.70 US$402,800
2017-03-02 2017-03-01 S Sale Gao David

Chief Executive Officer

Executive Director
54,049 -12.0%
100.57
US$5,435,708 		54,049 -12.0% 100.57 US$5,435,708
2017-03-02 2017-02-28 S Sale Gao David

Chief Executive Officer

Executive Director
62,604 -12.2%
100.69
US$6,303,597 		62,604 -12.2% 100.69 US$6,303,597
2016-08-17 2016-08-15 S Sale Yin Ming

Sr. Corporate Vice President

Officer
20,334 -55.3%
124.32
US$2,527,923 		20,334 -55.3% 124.32 US$2,527,923
2016-08-17 2016-08-15 S Sale Liu Wenfang Non-Executive Director
2,900 -46.2%
124.32
US$360,528 		2,900 -46.2% 124.32 US$360,528
2016-08-17 2016-08-15 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
1,968 -100.0%
124.32
US$244,662 		1,968 -100.0% 124.32 US$244,662
2016-08-17 2016-08-15 S Sale Yang Ming

Chief Financial Officer

Officer
21,092 -46.0%
124.32
US$2,622,157 		21,092 -46.0% 124.32 US$2,622,157
2016-08-17 2016-08-15 S Sale Yang Gang CBPO

Corporate Vice President

Officer
8,400 -20.7%
124.32
US$1,044,288 		8,400 -20.7% 124.32 US$1,044,288
2016-06-08 2016-06-08 S Sale Fang Min Non-Executive Director
2,775,000 -67.9%
111.00
US$308,025,000 		2,775,000 -67.9% 111.00 US$308,025,000
2016-06-08 2016-06-08 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
2,775,000 -67.9%
111.00
US$308,025,000 		2,775,000 -67.9% 111.00 US$308,025,000
2016-06-08 2016-06-08 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
2,775,000 -67.9%
111.00
US$308,025,000 		2,775,000 -67.9% 111.00 US$308,025,000
2016-05-23 2016-05-20 S Sale Yang Ming

Chief Financial Officer

Officer
6,129 -13.8%
113.40
US$695,029 		6,129 -13.8% 113.40 US$695,029
2016-05-23 2016-05-20 S Sale Yin Ming

Senior Corporate VP

Officer
8,645 -21.4%
113.40
US$980,343 		8,645 -21.4% 113.40 US$980,343
2016-05-23 2016-05-20 S Sale Yang Gang CBPO

Corporate Vice President

Officer
11,705 -24.7%
113.40
US$1,327,347 		11,705 -24.7% 113.40 US$1,327,347
2016-05-23 2016-05-19 S Sale Yang Ming

Chief Financial Officer

Officer
7,779 -14.9%
113.83
US$885,484 		7,779 -14.9% 113.83 US$885,484
2016-05-23 2016-05-19 S Sale Yin Ming

Senior Corporate VP

Officer
10,973 -21.3%
113.83
US$1,249,057 		10,973 -21.3% 113.83 US$1,249,057
2016-05-23 2016-05-19 S Sale Yang Gang CBPO

Corporate Vice President

Officer
14,858 -23.9%
113.83
US$1,691,286 		14,858 -23.9% 113.83 US$1,691,286
2016-03-15 2016-03-11 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
282 -28.2%
108.00
US$30,456 		282 -28.2% 108.00 US$30,456
2016-03-09 2016-03-07 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
4,257,000 -51.0%
107.00
US$455,499,000 		4,257,000 -51.0% 107.00 US$455,499,000
2016-03-09 2016-03-07 S Sale Fang Min Non-Executive Director
4,257,000 -51.0%
107.00
US$455,499,000 		4,257,000 -51.0% 107.00 US$455,499,000
2016-03-09 2016-03-07 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
4,257,000 -51.0%
107.00
US$455,499,000 		4,257,000 -51.0% 107.00 US$455,499,000
2015-12-08 2015-12-07 S Sale Tong Zhijun Non-Executive Director
4,514 -24.4%
119.00
US$537,166 		4,514 -24.4% 119.00 US$537,166
2015-12-08 2015-12-04 S Sale Tong Zhijun Non-Executive Director
10,000 -41.7%
118.00
US$1,180,000 		10,000 -41.7% 118.00 US$1,180,000
2015-12-08 2015-12-04 S Sale Tong Zhijun Non-Executive Director
486 -3.4%
119.00
US$57,834 		486 -3.4% 119.00 US$57,834
2015-11-05 2015-11-04 PlS Planned sale Gao David

Chief Executive Officer

Executive Director
7,460 -1.9%
115.19
US$859,317 		7,460 -1.9% 115.19 US$859,317
2015-11-03 2015-11-02 PlS Planned sale Gao David

Chief Executive Officer

Executive Director
4,009 -0.8%
115.02
US$461,115 		4,009 -0.8% 115.02 US$461,115
2015-10-30 2015-10-29 PlS Planned sale Gao David

Chief Executive Officer

Executive Director
9,458 -1.9%
110.08
US$1,041,137 		9,458 -1.9% 110.08 US$1,041,137
2015-10-27 2015-10-26 PlS Planned sale Gao David

Chief Executive Officer

Executive Director
6,289 -1.1%
105.33
US$662,424 		6,289 -1.1% 105.33 US$662,424
2015-09-16 2015-09-15 S Sale Yang Ming

Chief Financial Officer

Officer
9,000 -26.6%
94.56
US$851,040 		9,000 -26.6% 94.56 US$851,040
2015-09-16 2015-09-15 S Sale Yin Ming

Senior Corporate VP

Officer
13,134 -49.4%
94.65
US$1,243,133 		13,134 -49.4% 94.65 US$1,243,133
2015-09-16 2015-09-14 S Sale Liu Wenfang Non-Executive Director
2,717 -45.3%
97.02
US$263,603 		2,717 -45.3% 97.02 US$263,603
2015-09-16 2015-09-14 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
6,786 -100.0%
99.29
US$673,782 		6,786 -100.0% 99.29 US$673,782
2015-09-16 2015-09-14 S Sale Yang Gang CBPO

Corporate Vice President

Officer
5,341 -32.8%
97.02
US$518,184 		5,341 -32.8% 97.02 US$518,184
2015-06-17 2015-06-15 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
2,645,000 -24.1%
100.28
US$265,227,375 		2,645,000 -24.1% 100.28 US$265,227,375
2015-06-17 2015-06-15 S Sale WP X Biologics LLC Non-Executive Director Large shareholder
2,645,000 -24.1%
100.28
US$265,227,375 		2,645,000 -24.1% 100.28 US$265,227,375
2015-06-17 2015-06-15 S Sale Li David Hui Non-Executive Director
2,645,000 -24.1%
100.28
US$265,227,375 		2,645,000 -24.1% 100.28 US$265,227,375
2014-11-25 2014-11-21 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
8,000 -72.5%
68.95
US$551,600 		8,000 -72.5% 68.95 US$551,600
2014-11-12 2014-11-10 S Sale Shao Sean Non-Executive Director
2,500 -11.1%
62.75
US$156,875 		2,500 -11.1% 62.75 US$156,875
2014-11-12 2014-11-10 S Sale Shao Sean Non-Executive Director
30,000 -57.1%
62.75
US$1,882,500 		30,000 -57.1% 62.75 US$1,882,500
2014-11-12 2014-11-10 S Sale Shao Sean Non-Executive Director
40,000 -43.2%
62.75
US$2,510,000 		40,000 -43.2% 62.75 US$2,510,000
2014-11-12 2014-11-10 S Sale Liu Zhijing CBPO

Corporate Vice President

Officer
7,500 -71.2%
62.75
US$470,625 		7,500 -71.2% 62.75 US$470,625
2014-11-12 2014-11-10 S Sale Liu Wenfang Non-Executive Director
7,080 -100.0%
62.75
US$444,270 		7,080 -100.0% 62.75 US$444,270
2014-11-12 2014-11-10 S Sale Liu Wenfang Non-Executive Director
500 -6.6%
62.75
US$31,375 		500 -6.6% 62.75 US$31,375
2013-05-15 2013-05-14 B Purchase WP X Biologics LLC Non-Executive Director Large shareholder
3,112,920 +39.5%
20.00
US$62,258,400 		3,112,920 +39.5% 20.00 US$62,258,400
2012-11-30 2012-11-28 S Sale Zhao Chao Ming

President

Officer
200,000 -24.3%
15.00
US$3,000,000 		200,000 -24.3% 15.00 US$3,000,000
2012-09-17 2012-09-13 B Purchase Gao David

Chief Executive Officer

Executive Director
5,000 +71.4%
8.93
US$44,641 		5,000 +71.4% 8.93 US$44,641
2012-06-05 2012-06-01 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
1,608,363 +25.7%
12.50
US$20,104,538 		1,608,363 +25.7% 12.50 US$20,104,538
2012-05-15 2012-05-14 B Purchase Gao David

Chief Executive Officer

Executive Director
2,710 +63.2%
9.50
US$25,745 		2,710 +63.2% 9.50 US$25,745
2012-05-14 2012-05-11 B Purchase Gao David

Chief Executive Officer

Executive Director
4,290 +inf%
9.50
US$40,755 		4,290 +inf% 9.50 US$40,755
2011-12-19 2011-12-16 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
253,236 +4.2%
11.44
US$2,895,931 		253,236 +4.2% 11.44 US$2,895,931
2011-12-16 2011-12-15 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
216,146 +3.7%
11.33
US$2,447,940 		216,146 +3.7% 11.33 US$2,447,940
2011-12-16 2011-12-14 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
37,315 +0.6%
11.59
US$432,488 		37,315 +0.6% 11.59 US$432,488
2011-12-14 2011-12-14 S Sale Kuo Yuyun Tristan

CFO

Officer
5,000 -100.0%
11.60
US$58,000 		5,000 -100.0% 11.60 US$58,000
2011-12-14 2011-12-13 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
31,904 +0.6%
11.65
US$371,570 		31,904 +0.6% 11.65 US$371,570
2011-12-14 2011-12-13 S Sale Kuo Yuyun Tristan

CFO

Officer
20,000 -100.0%
11.69
US$233,850 		20,000 -100.0% 11.69 US$233,850
2011-12-14 2011-12-12 S Sale Kuo Yuyun Tristan

CFO

Officer
25,000 -100.0%
11.34
US$283,500 		25,000 -100.0% 11.34 US$283,500
2011-12-14 2011-12-12 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
47,461 +0.8%
11.28
US$535,241 		47,461 +0.8% 11.28 US$535,241
2011-12-12 2011-12-09 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
49,600 +0.9%
11.53
US$572,012 		49,600 +0.9% 11.53 US$572,012
2011-12-09 2011-12-08 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
32,723 +0.6%
11.01
US$360,130 		32,723 +0.6% 11.01 US$360,130
2011-12-09 2011-12-07 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
25,066 +0.4%
10.51
US$263,361 		25,066 +0.4% 10.51 US$263,361
2011-12-07 2011-12-05 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
94,210 +1.7%
10.10
US$951,860 		94,210 +1.7% 10.10 US$951,860
2011-12-07 2011-12-05 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
6,630 +0.1%
9.62
US$63,781 		6,630 +0.1% 9.62 US$63,781
2011-12-05 2011-12-02 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
1,748 +0.0%
9.43
US$16,492 		1,748 +0.0% 9.43 US$16,492
2011-12-05 2011-12-01 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
6,133 +0.1%
8.58
US$52,639 		6,133 +0.1% 8.58 US$52,639
2011-12-01 2011-11-30 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
15,267 +0.3%
7.78
US$118,808 		15,267 +0.3% 7.78 US$118,808
2011-12-01 2011-11-29 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
28,421 +0.5%
7.33
US$208,414 		28,421 +0.5% 7.33 US$208,414
2011-05-31 2011-05-27 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
109,721 +2.1%
16.14
US$1,770,875 		109,721 +2.1% 16.14 US$1,770,875
2011-05-31 2011-05-26 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
97,440 +1.9%
16.26
US$1,584,111 		97,440 +1.9% 16.26 US$1,584,111
2011-05-26 2011-05-25 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
35,362 +0.7%
15.41
US$544,776 		35,362 +0.7% 15.41 US$544,776
2011-05-26 2011-05-24 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
257,114 +5.2%
15.15
US$3,896,408 		257,114 +5.2% 15.15 US$3,896,408
2011-05-24 2011-05-23 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
14,869 +0.3%
14.82
US$220,290 		14,869 +0.3% 14.82 US$220,290
2011-05-24 2011-05-20 B Purchase Warburg Pincus Private Equity X, L.P. Non-Executive Director Large shareholder
20,030 +0.4%
14.91
US$298,629 		20,030 +0.4% 14.91 US$298,629
Explore more

More insider trading research around China Biologic Products Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America